3101
TOYOBO CO.,LTD.
東洋紡株式会社Toyobo Co., Ltd. provides films and functional polymers, industrial materials, and healthcare and textile products worldwide. The company operates through the following segments: Films, Life Science, Environmental and Functional Materials, Functional Textiles, and Trading and Real Estate. The Films segment manufactures and sells packaging films, including PET, polyolefin, and nylon for food packaging, as well as heat-resistant PET films; industrial films, such as PET films for liquid crystal displays, optical uses, and other industrial applications, as well as synthetic papers and other products. The Life Science segment manufactures and sells bio-products, such as enzymes for diagnostics, pharmaceuticals, medical membranes, medical devices, and other products, as well as artificial kidney hollow fibers and seawater desalination membranes. The Environmental and Functional Materials segment manufactures and sells engineering plastics, industrial adhesives, photo-functional materials, water treatment membranes, functional filters, high-performance fibers, nonwoven fabrics, and other products. The Functional Textiles and Trading segment manufactures and sells airbag fabrics, functional textiles, apparel products, apparel textiles, apparel fibers, and other products. The Real Estate segment leases and manages real estate properties and others. Toyobo Co., Ltd. was founded in 1882 and is headquartered in Osaka, Japan.
Price
¥1,810
Market Cap
¥159.6B
Ent. Value
¥377.1B
Net Debt
−¥217.5B
Shares Out.
88.2M
P / E
79.6×
EV / EBIT
22.6×
P / Book
0.82×
P / NCAV
N/M
Div. Yield
2.21%
Financials
| Metric |
FY 2024
EDINET ↗ |
FY 2023
EDINET ↗ |
FY 2022
EDINET ↗ |
FY 2021
EDINET ↗ |
|---|---|---|---|---|
| Net Sales | ¥422.0B | ¥414.3B | ¥399.9B | ¥375.7B |
| Cost of Sales | ¥325.0B | ¥326.3B | ¥314.9B | ¥279.6B |
| Gross Profit | ¥97.1B | ¥88.0B | ¥85.0B | ¥96.1B |
| SG&A | ¥80.4B | ¥79.0B | ¥74.9B | ¥67.7B |
| Operating Income | ¥16.7B | ¥9.0B | ¥10.1B | ¥28.4B |
| Non-Operating Income | ¥3.2B | ¥3.7B | ¥2.4B | ¥2.4B |
| Dividend Income | ¥321M | ¥323M | ¥323M | ¥531M |
| Non-Operating Expenses | ¥9.2B | ¥5.7B | ¥5.9B | ¥7.7B |
| Interest Expense | ¥2.2B | ¥1.4B | ¥1.3B | ¥1.2B |
| Ordinary Income | ¥10.6B | ¥7.0B | ¥6.6B | ¥23.1B |
| Pre-tax Income | ¥7.2B | ¥5.6B | ¥612M | ¥14.8B |
| Income Taxes | ¥2.0B | ¥2.0B | ¥1.4B | ¥2.7B |
| Current Tax | ¥3.2B | ¥5.3B | ¥3.2B | ¥5.6B |
| Deferred Tax | ¥-1.3B | ¥-3.3B | ¥-1.8B | ¥-2.9B |
| Net Income (owners) | ¥2.0B | ¥2.5B | ¥-655M | ¥12.9B |
| Minority Interest | ¥3.2B | ¥1.1B | ¥-152M | ¥-804M |
| Comprehensive Income | ¥5.4B | ¥12.5B | ¥-1.2B | ¥12.1B |
| EBITDA | ¥39.4B | ¥28.8B | ¥29.1B | ¥48.5B |
| EPS | ¥22.73 | ¥27.87 | ¥-7.37 | ¥144.75 |
| Shares Outstanding | 88.2M | 88.1M | 88.3M | 88.9M |
| Shares Issued (total) | 89.0M | 89.0M | 89.0M | 89.0M |
| Treasury Shares | 0.9M | 0.9M | 0.7M | 0.2M |